カテゴリ： QYResearch, 世界, 医療/バイオ

非侵襲的出生前遺伝子検査技術の世界市場2025年：NIPT、NIPTプラス

■ 英語タイトル：Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8190）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8190
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[非侵襲的出生前遺伝子検査技術の世界市場2025年：NIPT、NIPTプラス]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は非侵襲的出生前遺伝子検査技術のグローバル市場について調査・分析し、世界の非侵襲的出生前遺伝子検査技術市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（NIPT、NIPTプラス）、用途別セグメント分析（染色体異常、生殖補助医療、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Illumina、Natera、LifeLabs、NiftyTest、Labcorp、Xcelom、Veritas、Sema4、CeGaT、BGI、Berry Genomics、Daan Gene、CapitalBio、Annoroad、Adiconなどが含まれています。非侵襲的出生前遺伝子検査技術のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、非侵襲的出生前遺伝子検査技術市場規模を算出する際に考慮しました。

・非侵襲的出生前遺伝子検査技術市場の概要
- 非侵襲的出生前遺伝子検査技術の種類別セグメント
- 世界の非侵襲的出生前遺伝子検査技術市場規模：タイプ別分析（NIPT、NIPTプラス）
- 非侵襲的出生前遺伝子検査技術の用途別セグメント
- 世界の非侵襲的出生前遺伝子検査技術市場規模：用途別分析（染色体異常、生殖補助医療、その他）
- 世界の非侵襲的出生前遺伝子検査技術市場規模予測（2020年-2031年）

・非侵襲的出生前遺伝子検査技術市場の成長トレンド
- 非侵襲的出生前遺伝子検査技術の地域別市場規模（2020年-2031年）
- 非侵襲的出生前遺伝子検査技術市場ダイナミクス
- 非侵襲的出生前遺伝子検査技術の業界動向
- 非侵襲的出生前遺伝子検査技術市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：NIPT、NIPTプラス
- 世界の非侵襲的出生前遺伝子検査技術のタイプ別市場規模（2020年-2025年）
- 世界の非侵襲的出生前遺伝子検査技術のタイプ別市場規模（2024年-2029年）

・用途別セグメント：染色体異常、生殖補助医療、その他
- 世界の非侵襲的出生前遺伝子検査技術の用途別市場規模（2020年-2025年）
- 世界の非侵襲的出生前遺伝子検査技術の用途別市場規模（2024年-2029年）

・非侵襲的出生前遺伝子検査技術の地域別市場規模
- 北米の非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- 米国の非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- ヨーロッパの非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- アジア太平洋の非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- 中国の非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- 日本の非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- 韓国の非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- インドの非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- オーストラリアの非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- 中南米の非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）
- 中東・アフリカの非侵襲的出生前遺伝子検査技術市場規模（2020年-2031年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Illumina、Natera、LifeLabs、NiftyTest、Labcorp、Xcelom、Veritas、Sema4、CeGaT、BGI、Berry Genomics、Daan Gene、CapitalBio、Annoroad、Adicon

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Noninvasive Prenatal Gene Testing Technology market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Noninvasive Prenatal Gene Testing Technology is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Noninvasive Prenatal Gene Testing Technology is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Noninvasive Prenatal Gene Testing Technology in Chromosomal Abnormalities is estimated to increase from $ million in 2023 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global companies of Noninvasive Prenatal Gene Testing Technology include Illumina, Natera, LifeLabs, NiftyTest, Labcorp, Xcelom, Veritas, Sema4 and CeGaT, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Noninvasive Prenatal Gene Testing Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Noninvasive Prenatal Gene Testing Technology.
The Noninvasive Prenatal Gene Testing Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Noninvasive Prenatal Gene Testing Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Noninvasive Prenatal Gene Testing Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Illumina
Natera
LifeLabs
NiftyTest
Labcorp
Xcelom
Veritas
Sema4
CeGaT
BGI
Berry Genomics
Daan Gene
CapitalBio
Annoroad
Adicon
Segment by Type
NIPT
NIPT Plus
Segment by Application
Chromosomal Abnormalities
Assisted Reproduction
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Noninvasive Prenatal Gene Testing Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NIPT
1.2.3 NIPT Plus
1.3 Market by Application
1.3.1 Global Noninvasive Prenatal Gene Testing Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Chromosomal Abnormalities
1.3.3 Assisted Reproduction
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Noninvasive Prenatal Gene Testing Technology Market Perspective (2020-2031)
2.2 Noninvasive Prenatal Gene Testing Technology Growth Trends by Region
2.2.1 Global Noninvasive Prenatal Gene Testing Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Noninvasive Prenatal Gene Testing Technology Historic Market Size by Region (2020-2025)
2.2.3 Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Region (2026-2031)
2.3 Noninvasive Prenatal Gene Testing Technology Market Dynamics
2.3.1 Noninvasive Prenatal Gene Testing Technology Industry Trends
2.3.2 Noninvasive Prenatal Gene Testing Technology Market Drivers
2.3.3 Noninvasive Prenatal Gene Testing Technology Market Challenges
2.3.4 Noninvasive Prenatal Gene Testing Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Prenatal Gene Testing Technology Players by Revenue
3.1.1 Global Top Noninvasive Prenatal Gene Testing Technology Players by Revenue (2020-2025)
3.1.2 Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Players (2020-2025)
3.2 Global Noninvasive Prenatal Gene Testing Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Noninvasive Prenatal Gene Testing Technology Revenue
3.4 Global Noninvasive Prenatal Gene Testing Technology Market Concentration Ratio
3.4.1 Global Noninvasive Prenatal Gene Testing Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Prenatal Gene Testing Technology Revenue in 2022
3.5 Noninvasive Prenatal Gene Testing Technology Key Players Head office and Area Served
3.6 Key Players Noninvasive Prenatal Gene Testing Technology Product Solution and Service
3.7 Date of Enter into Noninvasive Prenatal Gene Testing Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Noninvasive Prenatal Gene Testing Technology Breakdown Data by Type
4.1 Global Noninvasive Prenatal Gene Testing Technology Historic Market Size by Type (2020-2025)
4.2 Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Type (2026-2031)
5 Noninvasive Prenatal Gene Testing Technology Breakdown Data by Application
5.1 Global Noninvasive Prenatal Gene Testing Technology Historic Market Size by Application (2020-2025)
5.2 Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Noninvasive Prenatal Gene Testing Technology Market Size (2020-2031)
6.2 North America Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2020-2025)
6.4 North America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Noninvasive Prenatal Gene Testing Technology Market Size (2020-2031)
7.2 Europe Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country (2020-2025)
7.4 Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size (2020-2031)
8.2 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Noninvasive Prenatal Gene Testing Technology Market Size (2020-2031)
9.2 Latin America Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2020-2025)
9.4 Latin America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size (2020-2031)
10.2 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Noninvasive Prenatal Gene Testing Technology Introduction
11.1.4 Illumina Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Natera
11.2.1 Natera Company Detail
11.2.2 Natera Business Overview
11.2.3 Natera Noninvasive Prenatal Gene Testing Technology Introduction
11.2.4 Natera Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.2.5 Natera Recent Development
11.3 LifeLabs
11.3.1 LifeLabs Company Detail
11.3.2 LifeLabs Business Overview
11.3.3 LifeLabs Noninvasive Prenatal Gene Testing Technology Introduction
11.3.4 LifeLabs Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.3.5 LifeLabs Recent Development
11.4 NiftyTest
11.4.1 NiftyTest Company Detail
11.4.2 NiftyTest Business Overview
11.4.3 NiftyTest Noninvasive Prenatal Gene Testing Technology Introduction
11.4.4 NiftyTest Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.4.5 NiftyTest Recent Development
11.5 Labcorp
11.5.1 Labcorp Company Detail
11.5.2 Labcorp Business Overview
11.5.3 Labcorp Noninvasive Prenatal Gene Testing Technology Introduction
11.5.4 Labcorp Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.5.5 Labcorp Recent Development
11.6 Xcelom
11.6.1 Xcelom Company Detail
11.6.2 Xcelom Business Overview
11.6.3 Xcelom Noninvasive Prenatal Gene Testing Technology Introduction
11.6.4 Xcelom Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.6.5 Xcelom Recent Development
11.7 Veritas
11.7.1 Veritas Company Detail
11.7.2 Veritas Business Overview
11.7.3 Veritas Noninvasive Prenatal Gene Testing Technology Introduction
11.7.4 Veritas Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.7.5 Veritas Recent Development
11.8 Sema4
11.8.1 Sema4 Company Detail
11.8.2 Sema4 Business Overview
11.8.3 Sema4 Noninvasive Prenatal Gene Testing Technology Introduction
11.8.4 Sema4 Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.8.5 Sema4 Recent Development
11.9 CeGaT
11.9.1 CeGaT Company Detail
11.9.2 CeGaT Business Overview
11.9.3 CeGaT Noninvasive Prenatal Gene Testing Technology Introduction
11.9.4 CeGaT Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.9.5 CeGaT Recent Development
11.10 BGI
11.10.1 BGI Company Detail
11.10.2 BGI Business Overview
11.10.3 BGI Noninvasive Prenatal Gene Testing Technology Introduction
11.10.4 BGI Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.10.5 BGI Recent Development
11.11 Berry Genomics
11.11.1 Berry Genomics Company Detail
11.11.2 Berry Genomics Business Overview
11.11.3 Berry Genomics Noninvasive Prenatal Gene Testing Technology Introduction
11.11.4 Berry Genomics Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.11.5 Berry Genomics Recent Development
11.12 Daan Gene
11.12.1 Daan Gene Company Detail
11.12.2 Daan Gene Business Overview
11.12.3 Daan Gene Noninvasive Prenatal Gene Testing Technology Introduction
11.12.4 Daan Gene Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.12.5 Daan Gene Recent Development
11.13 CapitalBio
11.13.1 CapitalBio Company Detail
11.13.2 CapitalBio Business Overview
11.13.3 CapitalBio Noninvasive Prenatal Gene Testing Technology Introduction
11.13.4 CapitalBio Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.13.5 CapitalBio Recent Development
11.14 Annoroad
11.14.1 Annoroad Company Detail
11.14.2 Annoroad Business Overview
11.14.3 Annoroad Noninvasive Prenatal Gene Testing Technology Introduction
11.14.4 Annoroad Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.14.5 Annoroad Recent Development
11.15 Adicon
11.15.1 Adicon Company Detail
11.15.2 Adicon Business Overview
11.15.3 Adicon Noninvasive Prenatal Gene Testing Technology Introduction
11.15.4 Adicon Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
11.15.5 Adicon Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NIPT
Table 3. Key Players of NIPT Plus
Table 4. Global Noninvasive Prenatal Gene Testing Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Noninvasive Prenatal Gene Testing Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Noninvasive Prenatal Gene Testing Technology Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Noninvasive Prenatal Gene Testing Technology Market Share by Region (2020-2025)
Table 8. Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Noninvasive Prenatal Gene Testing Technology Market Share by Region (2026-2031)
Table 10. Noninvasive Prenatal Gene Testing Technology Market Trends
Table 11. Noninvasive Prenatal Gene Testing Technology Market Drivers
Table 12. Noninvasive Prenatal Gene Testing Technology Market Challenges
Table 13. Noninvasive Prenatal Gene Testing Technology Market Restraints
Table 14. Global Noninvasive Prenatal Gene Testing Technology Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Noninvasive Prenatal Gene Testing Technology Market Share by Players (2020-2025)
Table 16. Global Top Noninvasive Prenatal Gene Testing Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Prenatal Gene Testing Technology as of 2022)
Table 17. Ranking of Global Top Noninvasive Prenatal Gene Testing Technology Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Noninvasive Prenatal Gene Testing Technology Revenue (CR5 and HHI) & (2020-2025)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Noninvasive Prenatal Gene Testing Technology Product Solution and Service
Table 21. Date of Enter into Noninvasive Prenatal Gene Testing Technology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Noninvasive Prenatal Gene Testing Technology Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Type (2020-2025)
Table 25. Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Type (2026-2031)
Table 27. Global Noninvasive Prenatal Gene Testing Technology Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Application (2020-2025)
Table 29. Global Noninvasive Prenatal Gene Testing Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Application (2026-2031)
Table 31. North America Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Noninvasive Prenatal Gene Testing Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Noninvasive Prenatal Gene Testing Technology Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Illumina Company Detail
Table 47. Illumina Business Overview
Table 48. Illumina Noninvasive Prenatal Gene Testing Technology Product
Table 49. Illumina Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 50. Illumina Recent Development
Table 51. Natera Company Detail
Table 52. Natera Business Overview
Table 53. Natera Noninvasive Prenatal Gene Testing Technology Product
Table 54. Natera Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 55. Natera Recent Development
Table 56. LifeLabs Company Detail
Table 57. LifeLabs Business Overview
Table 58. LifeLabs Noninvasive Prenatal Gene Testing Technology Product
Table 59. LifeLabs Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 60. LifeLabs Recent Development
Table 61. NiftyTest Company Detail
Table 62. NiftyTest Business Overview
Table 63. NiftyTest Noninvasive Prenatal Gene Testing Technology Product
Table 64. NiftyTest Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 65. NiftyTest Recent Development
Table 66. Labcorp Company Detail
Table 67. Labcorp Business Overview
Table 68. Labcorp Noninvasive Prenatal Gene Testing Technology Product
Table 69. Labcorp Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 70. Labcorp Recent Development
Table 71. Xcelom Company Detail
Table 72. Xcelom Business Overview
Table 73. Xcelom Noninvasive Prenatal Gene Testing Technology Product
Table 74. Xcelom Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 75. Xcelom Recent Development
Table 76. Veritas Company Detail
Table 77. Veritas Business Overview
Table 78. Veritas Noninvasive Prenatal Gene Testing Technology Product
Table 79. Veritas Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 80. Veritas Recent Development
Table 81. Sema4 Company Detail
Table 82. Sema4 Business Overview
Table 83. Sema4 Noninvasive Prenatal Gene Testing Technology Product
Table 84. Sema4 Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 85. Sema4 Recent Development
Table 86. CeGaT Company Detail
Table 87. CeGaT Business Overview
Table 88. CeGaT Noninvasive Prenatal Gene Testing Technology Product
Table 89. CeGaT Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 90. CeGaT Recent Development
Table 91. BGI Company Detail
Table 92. BGI Business Overview
Table 93. BGI Noninvasive Prenatal Gene Testing Technology Product
Table 94. BGI Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 95. BGI Recent Development
Table 96. Berry Genomics Company Detail
Table 97. Berry Genomics Business Overview
Table 98. Berry Genomics Noninvasive Prenatal Gene Testing Technology Product
Table 99. Berry Genomics Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 100. Berry Genomics Recent Development
Table 101. Daan Gene Company Detail
Table 102. Daan Gene Business Overview
Table 103. Daan Gene Noninvasive Prenatal Gene Testing Technology Product
Table 104. Daan Gene Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 105. Daan Gene Recent Development
Table 106. CapitalBio Company Detail
Table 107. CapitalBio Business Overview
Table 108. CapitalBio Noninvasive Prenatal Gene Testing Technology Product
Table 109. CapitalBio Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 110. CapitalBio Recent Development
Table 111. Annoroad Company Detail
Table 112. Annoroad Business Overview
Table 113. Annoroad Noninvasive Prenatal Gene Testing Technology Product
Table 114. Annoroad Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 115. Annoroad Recent Development
Table 116. Adicon Company Detail
Table 117. Adicon Business Overview
Table 118. Adicon Noninvasive Prenatal Gene Testing Technology Product
Table 119. Adicon Revenue in Noninvasive Prenatal Gene Testing Technology Business (2020-2025) & (US$ Million)
Table 120. Adicon Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Noninvasive Prenatal Gene Testing Technology Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 2. Global Noninvasive Prenatal Gene Testing Technology Market Share by Type: 2022 VS 2029
Figure 3. NIPT Features
Figure 4. NIPT Plus Features
Figure 5. Global Noninvasive Prenatal Gene Testing Technology Market Size Comparison by Application (2025-2031) & (US$ Million)
Figure 6. Global Noninvasive Prenatal Gene Testing Technology Market Share by Application: 2022 VS 2029
Figure 7. Chromosomal Abnormalities Case Studies
Figure 8. Assisted Reproduction Case Studies
Figure 9. Others Case Studies
Figure 10. Noninvasive Prenatal Gene Testing Technology Report Years Considered
Figure 11. Global Noninvasive Prenatal Gene Testing Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Noninvasive Prenatal Gene Testing Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Noninvasive Prenatal Gene Testing Technology Market Share by Region: 2022 VS 2029
Figure 14. Global Noninvasive Prenatal Gene Testing Technology Market Share by Players in 2024
Figure 15. Global Top Noninvasive Prenatal Gene Testing Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Prenatal Gene Testing Technology as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Noninvasive Prenatal Gene Testing Technology Revenue in 2024
Figure 17. North America Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Noninvasive Prenatal Gene Testing Technology Market Share by Country (2020-2031)
Figure 19. United States Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Noninvasive Prenatal Gene Testing Technology Market Share by Country (2020-2031)
Figure 23. Germany Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Noninvasive Prenatal Gene Testing Technology Market Share by Region (2020-2031)
Figure 31. China Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Noninvasive Prenatal Gene Testing Technology Market Share by Country (2020-2031)
Figure 39. Mexico Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Share by Country (2020-2031)
Figure 43. Turkey Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Noninvasive Prenatal Gene Testing Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Illumina Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 46. Natera Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 47. LifeLabs Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 48. NiftyTest Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 49. Labcorp Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 50. Xcelom Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 51. Veritas Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 52. Sema4 Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 53. CeGaT Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 54. BGI Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 55. Berry Genomics Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 56. Daan Gene Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 57. CapitalBio Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 58. Annoroad Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 59. Adicon Revenue Growth Rate in Noninvasive Prenatal Gene Testing Technology Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

※参考情報

非侵襲的出生前遺伝子検査技術は、妊娠中の母体から簡単にサンプルを採取し、胎児の遺伝的情報を分析することで、胎児の健康状態や特定の遺伝病のリスクを評価する技術です。この技術は、従来の侵襲的な検査に比べて母体や胎児へのリスクを軽減できるため、近年急速に普及しています。

まず、非侵襲的出生前遺伝子検査の定義について説明します。この検査は、母体の血液中に存在する胎児由来の細胞外遊離DNA（cfDNA）を分析する手法です。妊娠中の母体の血液中には、母体のDNAだけでなく、胎児由来のDNAも混在しています。この胎児由来のDNAを解析することにより、特定の遺伝子異常や染色体異常を判定することができます。

次に、この技術の特徴について述べます。非侵襲的な検査であるため、従来の羊水検査や絨毛膜検査のように、手術を伴わないという大きな利点があります。これにより、流産のリスクが大幅に低下し、妊娠中の母体の健康も守られます。また、この検査は一度の血液採取で複数の遺伝的な情報を検出できるため、非常に効率的です。加えて、比較的早い段階（妊娠10週以降）から実施可能で、結果も数日から数週間以内に得られるため、迅速な対応が可能です。

非侵襲的出生前遺伝子検査には、いくつかの種類があります。最も一般的なものは、染色体異常を検出するためのNIPT（Non-Invasive Prenatal Testing）です。この検査は、特にダウン症候群（21トリソミー）、エドワーズ症候群（18トリソミー）、パタウ症候群（13トリソミー）などの染色体異常に対するリスクを判定します。また、最近では、特定の遺伝子疾患に対する解析も行われており、CF（嚢胞性線維症）やSMA（脊髄性筋萎縮症）などの遺伝的要因に基づく疾患のリスク評価が可能です。

用途については、非侵襲的出生前遺伝子検査が、胎児の健康状態を評価するのみならず、妊娠中の母体にとっても有意義です。例えば、家族に遺伝的な疾患がある場合、NIPTを用いてリスクを事前に把握することで、出産前に適切な準備や医療措置を取ることができます。また、妊娠後期における産科医の管理や決定にも役立つ情報を提供します。そのため、関連する産科や遺伝医療の専門医との連携が重要です。

関連技術としては、遺伝子解析技術の進展が挙げられます。次世代シーケンシング（NGS）は、非侵襲的出生前遺伝子検査の基盤技術となっており、高速かつ高精度な解析が可能です。これにより、より多くの遺伝子異常や変異の網羅的な検出が実現できます。また、バイオインフォマティクスが進化することで、データ解析や結果解釈がより効率的に行われ、臨床現場での応用が促進されています。

さらに、この技術の倫理的側面についても考慮する必要があります。非侵襲的出生前遺伝子検査は、胎児の遺伝情報を早期に把握することが可能ですが、結果によっては妊婦が心理的な負担を感じることもあります。そのため、検査を行う前には十分な説明とカウンセリングが求められることが重要です。

非侵襲的出生前遺伝子検査技術は、将来の医療においてますます重要な役割を果たすことが期待されています。特に、リスクが高い妊婦や遺伝的疾患の家族歴がある妊婦にとって、この技術は非常に有用です。また、社会全体においても、出生前の健康管理の精度が向上し、健康な子どもの出生率の向上につながることが望まれます。

今後も、この分野における研究と技術開発が進むことで、より多くの遺伝的情報の解析が可能になるとともに、検査の精度や安全性が向上することが期待されます。新たな技術の導入や、他の医療分野との統合も進められることで、より包括的な医療サービスの提供が期待されます。

結論として、非侵襲的出生前遺伝子検査技術は、母体と胎児にやさしい方法で遺伝的情報を得る手段として、今後ますます重要性を増すことでしょう。医療提供者や妊婦自身がこの技術の特性を理解し、適切に活用することで、より健康な未来を築くための一助となることを願っています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • NIPT(新型出生前診断)のグローバル市場（2024～2030）：ゲノム、プロテオミクス、メタボローム、イメージング、その他
  • 非侵襲的出生前検査（NIPT）のグローバル市場（～2027）：ハードウェア、ソフトウェア
  • 非侵襲的出生前検査（NIPT）のグローバル市場：消耗品、器具
  • 非侵襲的出生前検査（NIPT）の世界市場予測（～2029）：製品＆サービス別、方法別、エンドユーザー別
  • IC試験サービスの世界市場2025年：外観検査試験、機能試験、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8190 )"非侵襲的出生前遺伝子検査技術の世界市場2025年：NIPT、NIPTプラス" (英文：Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。